Skip to content
Search

Latest Stories

PDA calls on employers to support prov-reg pharmacists with study and revision leave

The Pharmacists Defence Association (PDA) has urged pharmacy employers to support prov-regs pharmacists by allowing the study and revision leave they may need ahead of taking their exams.

“The cohort are concerned that their employers are becoming less supportive and may not agree to the exam preparation leave they need,” the PDA said in a statement today (Nov 18).


“As the next wave of the pandemic manifests and preparation for the vaccination programme makes clear the unprecedented scale of the task ahead, pharmacists will be needed more than ever.  Nevertheless, the population of prov-reg pharmacists and those who are re-sitting the exam still need to have adequate time to prepare,” it added.

The PDA is hearing from members who say their employers are suggesting that approving leave for exam preparation would be more difficult due to the pandemic workload.

The association believes the whole sector should be supporting budding pharmacists to have a fair chance of passing their exam.

“Making it even harder for the prov-regs to pass could cause further problems to the sector; if prov- regs fail, they will be immediately removed from the register and that could mean hundreds of pharmacists disappear from the profession at the height of the vaccination programme during the second wave of the pandemic,” the PDA has cautioned.

The pharmacy regulator, GPhC, previously confirmed that their online assessment would be held on a date in the first quarter of 2021, while avoiding the first two weeks of January. There is a possibility that online assessment for prov-regs and pre-reg resitters could be announced with only two months’ notice.

This means that any day from November 18, the regulator could announce that the exam will be held in two months’ time; such a short time frame makes the planning of study and revision leave a bigger challenge for employers, prov-regs and re-sitters, but it is essential.

“The PDA are reiterating our call for all employers to ensure that the 2020 cohort, many of whom have worked throughout the pandemic, are given the time off for study and revision that they need,” the association noted.

“There is a readily available population of locums in the sector so employers can begin making arrangements to secure cover and enable reasonable and planned time off for those taking the assessment examination,” the PDA concluded.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less